937 related articles for article (PubMed ID: 18554661)
21. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
22. Multicenter study of human immunodeficiency virus-related germ cell tumors.
Powles T; Bower M; Daugaard G; Shamash J; De Ruiter A; Johnson M; Fisher M; Anderson J; Mandalia S; Stebbing J; Nelson M; Gazzard B; Oliver T
J Clin Oncol; 2003 May; 21(10):1922-7. PubMed ID: 12743144
[TBL] [Abstract][Full Text] [Related]
23. Exploration of treatment options for the management of stage I testicular seminoma.
Bernal F; Raman JD
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1081-90. PubMed ID: 18588453
[TBL] [Abstract][Full Text] [Related]
24. Surveillance in stage I testicular seminoma - risk of late relapse.
Chung P; Parker C; Panzarella T; Gospodarowicz MK; Jewett S; Milosevic MF; Catton CN; Bayley AJ; Tew-George B; Moore M; Sturgeon JF; Warde P
Can J Urol; 2002 Oct; 9(5):1637-40. PubMed ID: 12431325
[TBL] [Abstract][Full Text] [Related]
25. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
[TBL] [Abstract][Full Text] [Related]
26. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
[TBL] [Abstract][Full Text] [Related]
27. [Testicular germ cell tumors: prognosis].
Miladi M; Peyromaure M; Remi J; Beuzeboc P; Debre B; Zerbib M
Prog Urol; 2003 Feb; 13(1):92-7. PubMed ID: 12703360
[TBL] [Abstract][Full Text] [Related]
28. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
[TBL] [Abstract][Full Text] [Related]
29. Management of stage I testicular seminoma over a period of 49 years.
Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
[TBL] [Abstract][Full Text] [Related]
30. Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men.
Fosså SD; Chen J; Schonfeld SJ; McGlynn KA; McMaster ML; Gail MH; Travis LB
J Natl Cancer Inst; 2005 Jul; 97(14):1056-66. PubMed ID: 16030303
[TBL] [Abstract][Full Text] [Related]
31. Testicular cancer: maintaining the high cure rate.
Raghavan D
Oncology (Williston Park); 2003 Feb; 17(2):218-28; discussion 228-9, 234-5, passim. PubMed ID: 12632864
[TBL] [Abstract][Full Text] [Related]
32. [Current procedure for treating testicular germ-cell tumors].
Tiuliandin SA; Figurin KM; Garin AM
Urol Nefrol (Mosk); 1995; (6):40-4. PubMed ID: 8686125
[TBL] [Abstract][Full Text] [Related]
33. Stage I seminoma: what should a practicing uro-oncologist do in 2009?
Skliarenko J; Vesprini D; Warde P
Int J Urol; 2009 Jun; 16(6):544-51. PubMed ID: 19453548
[TBL] [Abstract][Full Text] [Related]
34. Malignant germ cell tumors in childhood: results of the first Italian cooperative study "TCG 91".
Lo Curto M; Lumia F; Alaggio R; Cecchetto G; Almasio P; Indolfi P; Siracusa F; Bagnulo S; De Bernardi B; De Laurentis T; Di Cataldo A; Tamaro P
Med Pediatr Oncol; 2003 Nov; 41(5):417-25. PubMed ID: 14515380
[TBL] [Abstract][Full Text] [Related]
35. The changing presentation of germ cell tumours of the testis between 1983 and 2002.
Powles TB; Bhardwa J; Shamash J; Mandalia S; Oliver T
BJU Int; 2005 Jun; 95(9):1197-200. PubMed ID: 15892800
[TBL] [Abstract][Full Text] [Related]
36. [Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].
van Veelen LR; Steyerberg EW; Cleton FJ; Keizer HJ
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):564-8. PubMed ID: 10321275
[TBL] [Abstract][Full Text] [Related]
37. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection.
Hermans BP; Sweeney CJ; Foster RS; Einhorn LE; Donohue JP
J Urol; 2000 Jun; 163(6):1721-4. PubMed ID: 10799168
[TBL] [Abstract][Full Text] [Related]
38. [Testicular seminoma in stages I and II non-bulky. 16 years' experience].
Maranzano E; Latini P; Leggio M; Aristei C; Panizza BM; Perrucci E; Lupattelli M
Radiol Med; 1994 Jun; 87(6):865-9. PubMed ID: 8041942
[TBL] [Abstract][Full Text] [Related]
39. Reducing treatment toxicities in the management of good prognosis testicular germ cell tumors.
Gilbert DC; Van As NJ; Huddart RA
Expert Rev Anticancer Ther; 2009 Feb; 9(2):223-33. PubMed ID: 19192960
[TBL] [Abstract][Full Text] [Related]
40. Germinal cell tumors of the testis in cryptorchids.
Berkmen F; Alagöl H
J Exp Clin Cancer Res; 1998 Dec; 17(4):409-12. PubMed ID: 10089059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]